References
- OtakeHYasunagaHHoriguchiHMatsutaniNMatsudaSOheKImpact of hospital volume on chest tube duration, length of stay, and mortality after lobectomyAnn Thorac Surg20119231069107421871302
- VallieresEShepherdFACrowleyJInternational Association for the Study of Lung Cancer International Staging Committee and Participating InstitutionsThe IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancerJ Thorac Oncol2009491049105919652623
- AuJSMangOWFooWLawSCTime trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983–2000Lung Cancer200445214315215246184
- SistiJBoffettaPWhat proportion of lung cancer in never-smokers can be attributed to known risk factors?Int J Cancer2012131226527522322343
- NakamuraHSajiHWorldwide trend of increasing primary adenocarcinoma of the lungSurg Today20144461004101223754705
- SametJMAvila-TangEBoffettaPLung cancer in never smokers: clinical epidemiology and environmental risk factorsClin Cancer Res200915185626564519755391
- EppleinMSchwartzSMPotterJDWeissNSSmoking-adjusted lung cancer incidence among Asian-Americans (United States)Cancer Causes Control20051691085109016184474
- FonthamETCorreaPReynoldsPEnvironmental tobacco smoke and lung cancer in nonsmoking women – a multicenter studyJAMA1994271175217598196118
- KoYCLeeCHChenMJRisk factors for primary lung cancer among non-smoking women in TaiwanInt J Epidemiol199726124319126500
- SawabataNMiyaokaEAsamuraHJapanese Joint Committee for Lung Cancer RegistrationJapanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decadeJ Thorac Oncol2011671229123521610521
- GoyaTAsamuraHYoshimuraHJapanese Joint Committee of Lung Cancer RegistryPrognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry studyLung Cancer200550222723416061304
- AsamuraHGoyaTKoshiishiYJapanese Joint Committee of Lung Cancer RegistryA Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancersJ Thorac Oncol200831465218166840
- RosenJEHancockJGKimAWDetterbeckFCBoffaDJPredictors of mortality after surgical management of lung cancer in the National Cancer DatabaseAnn Thorac Surg20149861953196025443003
- PowellHATataLJBaldwinDRStanleyRAKhakwaniAHubbardRBEarly mortality after surgical resection for lung cancer: an analysis of the English national lung cancer auditThorax201368982683423687050
- GreenAHaugeJIachinaMJakobsenEThe mortality after surgery in primary lung cancer: results from the Danish Lung Cancer RegistryEur J Cardiothorac Surg201649258959425825264
- StrandTEBartnesKRostadHNational trends in lung cancer surgeryEur J Cardiothorac Surg20124235535822402451
- NagayasuTSatoSYamamotoHThe impact of certification of general thoracic surgeons on lung cancer mortality: a survey by The Japanese Association for Thoracic SurgeryEur J Cardiothorac Surg2016495e134e14026834236
- KondoRYoshidaKKawakamiSEfficacy of CT screening for lung cancer in never-smokers: analysis of Japanese cases detected using a low-dose CT screenLung Cancer201174342643221663997
- NakamuraHSajiHMarushimaHTagayaRKimuraHTakagiMGlucose uptake values in positron emission tomography are useful to predict survival after sublobar resection for lung cancerThorac Cardiovasc Surg Epub2242016
- SakuraiHAsamuraHGoyaTJapanese Joint Committee for Lung Cancer RegistrationSurvival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry studyJ Thorac Oncol20105101594160120736855
- NakamuraHAndoKShinmyoTFemale gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysisAnn Thorac Cardiovasc Surg201117546948021881356
- NakamuraHSajiHKurimotoNShinmyoTTagayaRImpact of intraoperative blood loss on long-term survival after lung cancer resectionAnn Thorac Cardiovasc Surg2015211182324583702
- JanjigianYYParkBJZakowskiMFImpact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutationsJ Thorac Oncol20116356957521150674